Document is current
Any future updates will be listed below
-
Authors
Chen, Siqing
Chen, Xiaotian
Meng, Shijie
Yuan, Qiang
Wu, Huiling
Hu, Weihang
Zhou, Li
Shan, Letian
-
Funding
Funding for this research was provided by:
Natural Science Foundation of China (82274373)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 22 September 2025
First Online: 28 October 2025
Declarations
:
: This study only extracted blood samples from experimental animals and did not conduct in vivo experiments. Experiments were carried out in accordance with the local guidelines for the care of laboratory animals of Zhejiang Chinese Medical University (SYXK (Zhe) 2021-0012) and all animal blood collection procedures were approved by the Experimental Animal Management and Ethics Committee of Zhejiang Chinese Medicine University (Approval No. 20220919-30). The date of approval is 2022.10.24. The human cell source (the Preparation Center of Hangzhou Sanjiang Shangyu Biotechnology Co., Ltd.) has confirmed that there was initial ethical approval for the collection of human cells and that the donors had signed informed consent. The company has signed a cooperation agreement with Hangzhou Ninth People’s Hospital, and Hangzhou Ninth People’s Hospital has a medical ethics review report.
: The authors declare no competing interests.
